Back to Search
JAMES TREAT, M.D.
Dermatology Physician
NPI: 1811947351IndividualAccepts Medicare
Specialties, Licenses & Credentials
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
MD428461(PA)
Education
PERELMAN SCHOOL OF MED AT THE UNIVERSITY OF PENNSYLVANIA
Class of 2002
Research & Publications (20)
Growth inhibition of Trichophyton species by Pseudomonas aeruginosa.
PMID 17224543·Arch Dermatol·2007
8-other
Incorporating novel agents with gemcitabine-based treatment of NSCLC.
PMID 16291433·Lung Cancer·2005
8-other
Topotecan in the treatment of relapsed small cell lung cancer patients with poor performance status.
PMID 15047921·Oncologist·2004
6-review
Topical nitrogen mustard ointment with occlusion for Langerhans' cell histiocytosis of the scalp.
PMID 12745855·J Dermatolog Treat·2003
5-case
ZD0473 treatment in lung cancer: an overview of the clinical trial results.
PMID 12645908·Eur J Cancer·2002
1-meta
Liposomal-encapsulated chemotherapy: preliminary results of a phase I study of a novel liposomal paclitaxel.
PMID 11396365·Oncology (Williston Park)·2001
6-review
Administration of pemetrexed immediately following gemcitabine as front-line therapy in advanced non-small cell lung cancer: a phase II trial.
PMID 16730854·Lung Cancer·2006
3-trial
A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa.
PMID 19185954·J Am Acad Dermatol·2009
3-trial
Costs of first-line doublet chemotherapy and lifetime medical care in advanced non-small-cell lung cancer in the United States.
PMID 18980633·Value Health·2009
8-other
Trends and predictors of first-line chemotherapy use among elderly patients with advanced non-small cell lung cancer in the United States.
PMID 18649969·Lung Cancer·2009
8-other
Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer.
PMID 19075278·J Clin Oncol·2009
3-trial
PROCLAIM: A phase III study of pemetrexed, cisplatin, and radiation therapy followed by consolidation pemetrexed versus etoposide, cisplatin, and radiation therapy followed by consolidation cytotoxic chemotherapy of choice in locally advanced stage III non-small-cell lung cancer of other than predominantly squamous cell histology.
PMID 19443340·Clin Lung Cancer·2009
3-trial
Phase II study of paclitaxel, carboplatin, and cetuximab as first line treatment, for patients with advanced non-small cell lung cancer (NSCLC): results of OPN-017.
PMID 18978564·J Thorac Oncol·2008
3-trial
A long-term follow-up of a single rural surgeon's experience with laparoscopic inguinal hernia repair.
PMID 18575098·WMJ·2008
8-other
Spread of cantharidin after petrolatum use resulting in a varicelliform vesicular dermatitis.
PMID 18625390·J Am Acad Dermatol·2008
5-case
Beyond first-line treatment: management strategies for maintaining acne improvement and compliance.
PMID 18924544·Cutis·2008
6-review
Phase I study of radical thoracic radiation, weekly irinotecan, and cisplatin in locally advanced non-small cell lung carcinoma.
PMID 17410043·J Thorac Oncol·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3550 MARKET ST FL 2, CHILDREN'S HOSPITAL OF PHILADELPHIA - DERMATOLOGY DIV
PHILADELPHIA, PA 19104 - Phone
- (215) 590-9119
Quick Facts
- NPI
- 1811947351
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile